BELEODAQ (BELINOSTAT) INJECTION

Belinostat (trade name Beleodaq, previously known as PXD101) is a histone deacetylase inhibitor drug developed by TopoTarget for the treatment of hematological malignancies and solid tumors.

BELEODAQ (belinostat) Injection suppliers in India. Allevaire India Network New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

ALLEVIARE LIFE SCIENCES connects the buyer with the supplier who can ship BELEODAQ (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. BELEODAQ is manufactured by Spectrum Pharmaceuticals, Inc.

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for BELEODAQ (belinostat) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Beleodaq is a histone deacetylase inhibitor indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

This indication is approved under accelerated approval based on tumor response rate and duration of response.

Medicine Name: BELEODAQ
Generic Name: belinostat
Approval Date: 2014
Available as (Form & Strength): For injection: 500 mg, lyophilized powder in single-use vial for reconstitution
Company Name: Spectrum Pharmaceuticals, Inc.